<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00665379</url>
  </required_header>
  <id_info>
    <org_study_id>NS1NL</org_study_id>
    <nct_id>NCT00665379</nct_id>
  </id_info>
  <brief_title>Comparative Trial in Compression Therapy in Leg Lymphedema</brief_title>
  <official_title>Prospective, Randomized Controlled Trial Comparing the Effect of 3M Coban 2 Layer Compression System Versus Trico Bandages in the Treatment of Leg Lymphedema.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nij Smellinghe Hosptial</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nij Smellinghe Hosptial</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to study the effect of the 3M Coban 2 Layer Compression System&#xD;
      (hereafter C2L) in the treatment of leg lymphedema compared to the traditional treatment with&#xD;
      Trico bandages.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this prospective, randomized, controlled trial with CE marked product is to study&#xD;
      the effectiveness (volume reduction) of 24-hour compression therapy for lymphedema, comparing&#xD;
      C2L and Trico bandaging. Therefore 30 patients with leg lymphedema are included.&#xD;
&#xD;
      Application of marketed compression bandages (C2L or Trico bandages) used for treatment by&#xD;
      trained specialists with assessment of the subbandage pressure and volume reduction.&#xD;
&#xD;
      Measurements are carried out at:&#xD;
&#xD;
      Volumetry:&#xD;
&#xD;
      Measurements after 0h, 2h and 24 h by using classic water displacement apparatus.&#xD;
&#xD;
      Pressure:&#xD;
&#xD;
      Measurements after 0h, 2h (pre and post bandage change) and 24 h;&#xD;
&#xD;
        -  supine and standing to calculate the SSI;&#xD;
&#xD;
        -  supine with and without dorsal flexion.&#xD;
&#xD;
      for the pressure measurement a Kikuhime (large pads) dice is used. At each new bandaging to&#xD;
      document the SSI and the effect of dorsiflexion in the supine position&#xD;
&#xD;
        -  The subbandage pressure is measured on the medial aspect of the lower leg at the&#xD;
           transition of the gastrocnemius muscle into the Achilles' tendon (B1) (Partsch H. et al.&#xD;
           Dermatol Surg 2006; 32: 224-233).&#xD;
&#xD;
        -  Fix the sensor (sensor and tube sheathed with Cellona Soft Padding)&#xD;
&#xD;
      Statistical analysis; Analysis of variance (ANOVA) comparing volume, supine subbandage&#xD;
      pressure with and without dorsiflexion, and SSI for the used bandages&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>volume decrease in relation to interface pressure after application of two types of bandages.</measure>
    <time_frame>enrollment of 30 patients</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pressure drop after 2 hours and 24 hours of bandaging</measure>
    <time_frame>after application, at 2 hours and 24 hours after application of bandage</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Leg Lymphedema</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular compression therapy with non elastic trico bandaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>New two layer compression bandage coban 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Regular Compression therapy (Trico bandages)</intervention_name>
    <description>Application of marketed Trico compression bandages used for treatment by trained specialists with assessment of the subbandage pressure and volume reduction. The bandages are applicated in patients with leg lymphedema at t=0 hour, t=2 hours. Comparison is made at t=2 hours, t= 24 hours</description>
    <arm_group_label>1</arm_group_label>
    <other_name>trico bandages</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>New Compression therapy (C2L bandages)</intervention_name>
    <description>Application of marketed compression bandages C2L used for treatment by trained specialists with assessment of the subbandage pressure and volume reduction. he bandages are applicated in patients with leg lymphedema at t=0 hour, t=2 hours. Comparison is made at t=2 hours, t= 24 hours</description>
    <arm_group_label>2</arm_group_label>
    <other_name>coban 2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Gender: male or female&#xD;
&#xD;
          -  More than 18 years of age&#xD;
&#xD;
          -  Patients with distal lymphedema of the leg requiring multilayer lymphedema bandaging&#xD;
             of the leg&#xD;
&#xD;
          -  The patient is able to understand the study and is willing to give written informed&#xD;
             consent to the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy against one of the used materials&#xD;
&#xD;
          -  Proximal lymphedema (involvement of thigh, genitalia)&#xD;
&#xD;
          -  Severe systemic diseases causing peripheral oedema&#xD;
&#xD;
          -  Acute superficial or deep vein thrombosis&#xD;
&#xD;
          -  Arterial occlusive disease (stadium II, III or IV) or arm/leg blood pressure index&#xD;
             (ALPI)&lt;0,8&#xD;
&#xD;
          -  Local infection in the therapy area&#xD;
&#xD;
          -  Auto-immunological disorders or vasculitis&#xD;
&#xD;
          -  Use of systemic corticosteroids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RJ Damstra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nij Smellinghe Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>H Partsch, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Private practice, wien</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nij Smellinghe hospital</name>
      <address>
        <city>Drachten</city>
        <state>Friesland</state>
        <zip>9202NN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <study_first_submitted>April 17, 2008</study_first_submitted>
  <study_first_submitted_qc>April 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2008</study_first_posted>
  <last_update_submitted>May 19, 2012</last_update_submitted>
  <last_update_submitted_qc>May 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nij Smellinghe Hosptial</investigator_affiliation>
    <investigator_full_name>R.J. Damstra</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>leg lymphedema</keyword>
  <keyword>volume measurement</keyword>
  <keyword>compression therapy</keyword>
  <keyword>interface pressure</keyword>
  <keyword>static stiffness index (SSI)</keyword>
  <keyword>volume change</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

